In welcoming the participants, President Jehuda Reinharz remarked on the impressive array of individuals who gathered to exchange ideas, business plans and investment opportunities as cutting edge life science firms aim to tackle some of the world’s most pressing medical challenges ranging from Alzheimer’s disease, cancer and obesity. He said, “together – Israelis and New Englanders alike – are determined to claim the common ground upon which business and science can build a more prosperous world.”
Keynote speaker Israel Makov, Chairman of Given Imaging, called on companies to break down the traditional silos that exist amongst firms which are tackling the most complex diseases. He urged them to form clusters and pursue “knowledge synergies” to spark innovation and improved productivity of their research and development efforts.
Kicking off the following day, featured speaker Dr. Paul A. Bleicher, Chief Medical Officer of Humedica, presented a vision for electronic health data improvements which he believed could ultimately lead to a ‘longitudinal medical record’ spanning the entire life cycle of a patient. This set the stage for the executives from firms developing new diagnostics, monitoring systems, and therapeutics for a wide variety of pressing health challenges to present their business plans. Each then held individual one-on-one meetings with potential strategic partners and investors.
The summit, organized by the New England-Israel Business Council, was co-hosted by the Consulate General of Israel to New England, the Government of Israel Economic Mission to North America, and the Brandeis International Business School (IBS). Brandeis IBS Dean Bruce R. Magid felt hosting the conference “supports the basic premise behind the creation of our school” with the participants “providing a critical span in this important cross-border bridge” between Israel and New England.